Headshot of Emily Hayes.

Emily Hayes

Contributing writer

Emily Hayes is a freelance journalist based in the California Bay Area. She has more than 25 years of experience writing about medicine across therapeutic areas for health-care professionals and investors. Among other trade publications, she has written for the pharmaceutical news titles Pink Sheet and Scrip.

From this contributor

Explore more from The Transmitter

SHANK3 deficiency and behavior in mice; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.

By Jill Adams
25 November 2025 | 2 min read

Remembering Mark Hallett, leader in transcranial magnetic stimulation

The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.

By David Dobbs
25 November 2025 | 7 min read

Autism scientists push back on CDC’s inaccurate vaccine claims

The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.

By The Transmitter
21 November 2025 | 6 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.